Infectious Agents and Cancer
A section of Cancers (ISSN 2072-6694).
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- The Role of Epstein–Barr Virus in Human Cancers (Deadline: 15 September 2025)
- Human Papillomavirus (HPV) and Related Cancer (Deadline: 31 October 2025)
- Epstein-Barr Virus-Associated Cancers: From Pathogenesis to Treatment (2nd Edition) (Deadline: 30 November 2025)
- Cancers in Chronic HIV Infection (Deadline: 31 December 2025)
- Harnessing the Gut Microbiome to Improve Colorectal Cancer Outcomes (Deadline: 25 February 2026)
- Understanding HTLV-1 Induced Cancer: From Molecular Pathways to Treatment Strategies (Deadline: 25 February 2026)
- Bacterial Infections and Cancer Risk: From Biological Mechanisms to Clinical Realities (Deadline: 25 March 2026)
- The Oral Microbiome and Its Link to Oral Cancer: Exploring the Role of Infectious Agents (Deadline: 31 March 2026)
- The Role of Viruses in the Development of Cancer (Deadline: 31 March 2026)
- Potential Therapeutic Targets and Non-Invasive Procedures for Improving the Treatment and Follow-Up of HPV-Associated Malignancies (2nd Edition) (Deadline: 30 April 2026)
- Advances in Virus-Associated Head and Neck Cancer (Deadline: 1 May 2026)
- Infectious Agents and Cancer in Children and Adolescents (Deadline: 15 May 2026)
- Viral Oncogenes and Their Role in Cancer Pathogenesis (Deadline: 21 May 2026)
- Infectious Agents and Oesophageal Cancer (2nd Edition) (Deadline: 31 May 2026)
- HIV-Associated Lymphoid Neoplasms (2nd Edition) (Deadline: 20 July 2026)
- Human Carcinogens—Chemical Agents, Occupational Exposure and Health Impact (Deadline: 31 August 2026)
